On the road with OIRO: Taking Science to the supermarket

Clinician and patient attitudes toward locoregional treatment of oligometastatic oesophago-gastric cancers: a mixed-methods study

Lakha AS. et al, (2026), ESMO Gastrointestinal Oncology, 13, 100382 - 100382

Can GLP-1RA be utilised for pre-operative liver optimisation prior to hepatectomy? A scoping review of MASLD evidence with surgical translation

Vaitha R. et al, (2026), Clinical Surgical Oncology, 5, 100136 - 100136

Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancer.

Gibson V. et al, (2026), Nat Commun, 17

Down-Regulation of Proline Rich Homeodomain/Haematopoietically Expressed Homeobox Expression in Prostate Cells Enables Tumour Initiation and Tumour Growth

Marcolino E. et al, (2026), Cancers, 18, 2247 - 2247

The pharmacological profile of ART6043, a first-in-class clinical DNA polymerase theta polymerase domain inhibitor potentiating PARP inhibitor efficacy.

Robinson HMR. et al, (2026), Clin Cancer Res

Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis.

Lopez-Lopez V. et al, (2026), J Natl Cancer Inst

CDIN1-Codanin-1 complex defective in congenital dyserythropoietic anaemia type I is an RNA nuclease.

Brolih S. et al, (2026), Nat Commun

Forging New Pathways in Oncology: Strategic Insights from the 17th Annual Frontiers in Cancer Science Conference.

Huang D. et al, (2026), Cancer Res, 86, 3106 - 3108

Tirapazamine sensitises hypoxic homologous recombination-proficient NSCLC to PARP inhibition.

Jiang Y. et al, (2026), Cell Death Discov

Addition of rituximab to first-line treatment of Burkitt lymphoma in children and young adults in Tanzania: a cost-utility analysis

MORRELL L. et al, (2026), Journal of Clinical Oncology Global Oncology

Identification of a Novel GOLGB1-RET Fusion in Papillary Thyroid Cancer With a Durable Response to Selpercatinib.

Boku S. et al, (2026), JCO Precis Oncol, 10

Diagnostic Implications of Multi-Cancer Early Detection Testing in the Investigation of Cancer Symptoms: An Exploratory Retrospective Analysis of the SYMPLIFY Study.

Jackson A. et al, (2026), Lancet Reg Health Eur, 66

Cell-Free DNA Analysis With Clinicopathologic Factors for Early Detection and Refining Lymph Node Metastasis Risk in T1 Colorectal Cancer: Results From the COSMOS-CRC Study.

Murano T. et al, (2026), JCO Precis Oncol, 10

Current status of radionuclide therapy targeting PARP in cancer: challenges and prospects.

Kurniawan A. et al, (2026), Eur J Nucl Med Mol Imaging

Genomic Prostate Score for Identifying Biologically Low-risk Disease in Patients with Prostate Cancer Undergoing Active Surveillance, Surgery, or Radiotherapy.

Sushentsev N. et al, (2026), Eur Urol Oncol

CT radiomics for survival risk stratification in resectable colorectal liver metastases: a multi-centre study.

Mian A. et al, (2026), Sci Rep, 16

Surgical outcomes in gallbladder cancer: evidence from the UK nationwide CAPBIL study.

McClements J. et al, (2026), HPB (Oxford)

3D pathology-guided microdissection.

Hsieh H-C. et al, (2026), Nat Methods

A multi-center clinical evaluation on first-in-class ROP-based IGRA for tuberculosis diagnosis.

Li Q. et al, (2026), iScience, 29

Pragmatism in academic gastrointestinal cancer clinical trials: An analysis of trials conducted by the EORTC gastrointestinal tract cancer group and the unicancer gastrointestinal group.

Puhr HC. et al, (2026), Eur J Cancer, 241

Search results

Showing results for